Tushar Barad

Pioneer in India to introduce international scale reporting of BCR/ABL Ratio for CML patients diagnosis and monitoring. Core expertise in Molecular Hematopathology, Leukemia(ALL, AML, CML, APML, etc) and Lymphoma(B & T cell Gene Rearrangement), Next Generation Sequencing sample prep QC technology and MRD(Minimal Residual Disease Monitoring) for Leukemias through NGS technology. Fragile X Mental Retardation diagnosis through PCR based technology.

View full profile on Docplexus ↗